![Andreas Krebs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 930 122 $ in data 30/06/2026
Andreas R.
Krebs is Vice Chairman at Definium Therapeutics, Inc. since 2021.
Mr. Krebs is Chairman at Forderverein Girassol.
E.
V.
Mr. Krebs is Trustee at Paul Ehrlich-Foundation.
Mr. Krebs is Trustee at Max-Planck-Institut für molekulare Biomedizin.
Mr. Krebs is Member of the Supervisory Board at Ober Scharrer Gruppe GmbH.
Former roles include Chairman of the Supervisory Board at Merz Beteiligungs GmbH.
From 2012 to 2019, Mr. Krebs was Chairman of the Supervisory Board at Merz Pharma GmbH & Co. KGaA. From 2010 to 2019, Mr. Krebs was Chairman of the Supervisory Board at City of Frankfurt am Main (Germany).
Mr. Krebs was President and Executive Director at Wyeth LLC.
Mr. Krebs was Co-Managing Director at Cologne Invest GmbH.
In 2009, Mr. Krebs was President-Europe, Middle East, Africa and Canada at Wyeth Pharmaceuticals LLC.
From 2011 to 2016, Mr. Krebs was Member of the Supervisory Board at Heidelberg Pharma AG.
Mr. Krebs was Member of the Supervisory Board at SENATOR GmbH.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 19.773 ( 0,01% ) | 930 122 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| DEFINIUM THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 29/09/2021 |
Paul Ehrlich-Foundation | Direttore/Membro del Consiglio | - |
Max-Planck-Institut für molekulare Biomedizin | Direttore/Membro del Consiglio | - |
Ober Scharrer Gruppe GmbH
 Ober Scharrer Gruppe GmbH Medical/Nursing ServicesHealth Services Provides outpatient eye surgery services | Direttore/Membro del Consiglio | - |
Forderverein Girassol E V | Presidente | - |
| Società | Posizione | Fine |
|---|---|---|
Merz Pharma GmbH & Co. KGaA
 Merz Pharma GmbH & Co. KGaA Miscellaneous Commercial ServicesCommercial Services Researches, develops, and sells drugs for the treatment of disorders in the area of neurology, psychiatry, dermatology | Presidente | 31/10/2019 |
City of Frankfurt am Main (Germany)
 City of Frankfurt am Main (Germany) MunicipalityGovernment Functions as a local level government authority | Presidente | 01/01/2019 |
| HEIDELBERG PHARMA AG | Direttore/Membro del Consiglio | 13/05/2016 |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Presidente | 01/10/2009 |
| ░░░░░ ░░░░░ | ░░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Heidelberg Pharma AG
 Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
SENATOR GmbH
 SENATOR GmbH Office Equipment/SuppliesProducer Manufacturing Manufactures & supplies pens and pencil products | Producer Manufacturing |
Merz Beteiligungs GmbH
 Merz Beteiligungs GmbH MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Merz Pharma GmbH & Co. KGaA
Merz Pharma GmbH & Co. KGaA Miscellaneous Commercial ServicesCommercial Services Researches, develops, and sells drugs for the treatment of disorders in the area of neurology, psychiatry, dermatology | Commercial Services |
City of Frankfurt am Main (Germany)
City of Frankfurt am Main (Germany) MunicipalityGovernment Functions as a local level government authority | Government |
Paul Ehrlich-Foundation | |
Max-Planck-Institut für molekulare Biomedizin | |
Ober Scharrer Gruppe GmbH
Ober Scharrer Gruppe GmbH Medical/Nursing ServicesHealth Services Provides outpatient eye surgery services | Health Services |
Cologne Invest GmbH
 Cologne Invest GmbH Investment ManagersFinance Cologne Invest invests in companies located in Germany. The firm focuses on a broad range of sectors. It participates in acquisitions and early-stage transactions. | Finance |
Mind Medicine (MindMed), Inc.
 Mind Medicine (MindMed), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company which develops novel products to treat brain health disorders | Health Technology |
Forderverein Girassol E V |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
